CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-30 | Mulholland Michael D. Chief Financial Officer | Grant or award | +100,000 | 284,081 | ||
| 2020-09-30 | Mulholland Michael D. Chief Financial Officer | Grant or award · Non-qualified Stock Option | +200,000 | 200,000 | ||
| 2020-09-30 | Kelly Scott A. Chairman & CMO | Grant or award | +250,000 | 1,741,052 | ||
| 2020-09-30 | Kelly Scott A. Chairman & CMO | Grant or award · Non-qualified Stock Option | +500,000 | 500,000 | ||
| 2020-09-30 | Pourhassan Nader President & CEO | Grant or award | +500,000 | 1,574,930 | ||
| 2020-09-30 | Pourhassan Nader President & CEO | Grant or award · Non-qualified Stock Option | +2,000,000 | 2,000,000 | ||
| 2020-08-28 | Kelly Scott A. Chairman & CMO | Gift | −74,800 | 616,408 | ||
| 2020-08-28 | Kelly Scott A. Chairman & CMO | Gift | +74,800 | 97,980 | ||
| 2020-07-31 | Pourhassan Nader President & CEO | Grant or award | +323,157 | 1,231,500 | ||
| 2020-07-31 | Pourhassan Nader President & CEO | Shares withheld for taxes | −156,570 | $4.97 | $778K | 1,074,930 |
| 2020-06-25 | Welch David F Director | Grant or award · Non-qualified Stock Option | +225,000 | 225,000 | ||
| 2020-06-25 | Patel Samir Rashmikant Director | Grant or award · Non-qualified Stock Option | +225,000 | 225,000 | ||
| 2020-06-25 | Naydenov Jordan G Director | Grant or award · Non-qualified Stock Option | +225,000 | 225,000 | ||
| 2020-06-25 | TIMMINS ALAN P Director | Grant or award · Non-qualified Stock Option | +225,000 | 225,000 | ||
| 2020-06-25 | Naydenov Jordan G Director | Grant or award · Non-qualified Stock | +225,000 | 225,000 | ||
| 2020-05-05 | Kelly Scott A. Chief Medical Officer | Option exercise · Nonqualified Option - right to buy | +8,334 | 25,000 | ||
| 2020-05-04 | Kelly Scott A. Chairman & CMO | Option exercise | +8,334 | $0.52 | $4K | 1,566,052 |
| 2020-05-04 | Kelly Scott A. Chairman & CMO | Option exercise · Nonqualified Stock Option-right to buy | +8,334 | 25,000 | ||
| 2020-05-04 | Kelly Scott A. Chief Medical Officer | Option exercise | +8,334 | $0.52 | $4K | 1,566,052 |
| 2020-05-04 | Pourhassan Nader President & CEO | Option exercise | +30,933 | $0.39 | $12K | 2,109,995 |
Page 12 of 33 · 652 trades